Virucidal Approaches for Hemorrhagic Fever Viruses
- PMID: 40431675
- PMCID: PMC12115516
- DOI: 10.3390/v17050663
Virucidal Approaches for Hemorrhagic Fever Viruses
Abstract
We have reviewed the primary literature on the virucidal efficacy of microbicidal active ingredients, formulated microbicides, and physical inactivation approaches (heat, irradiation) for hemorrhagic fever viruses (HFVs) (arenaviruses, filoviruses, flaviviruses, hantaviruses, nairoviruses, and phenuiviruses), and for two non-typical HFV paramyxoviruses. As each of these HFVs are large, lipid-enveloped RNA viruses, their susceptibilities to virucidal agents are informed by the so-called hierarchy of susceptibility of pathogens to microbicides. The unique susceptibility of lipid-enveloped viruses to most classes of microbicides is based on the common mechanisms of action of envelope-disrupting microbicides. Despite this, due to the relatively great lethality of these viruses, it is prudent (where possible) to confirm the expected efficacies of inactivation approaches in testing involving the HFVs themselves (as opposed to less lethal surrogate viruses) using field-relevant methods. Empirical data for virucidal activities of microbicidal active ingredients, formulated microbicides, and physical inactivation approaches, such as heat, ultraviolet light, and gamma irradiation, that were collected specifically for HFVs have been reviewed and summarized in this paper. These empirical data for surface and hand hygiene approaches, liquid inactivation approaches, and approaches for rendering diagnostic samples safe to handle inform non-pharmaceutical interventions intended to mitigate transmission risk associated with these HFVs.
Keywords: arenaviruses; filoviruses; flaviviruses; hand hygiene; hantaviruses; nairoviruses; paramyxoviruses; phenuiviruses; surface inactivation; suspension inactivation.
Conflict of interest statement
Raymond W. Nims is employed by Syner-G BioPharma, and M. Khalid Ijaz is employed by Reckitt Benckiser LLC. The authors declare no conflicts of interest.
References
-
- Ijaz M.K., Nims R.W., Cutts T.A., McKinney J., Gerba C.P. Predicted and measured virucidal efficacies of microbicides for emerging and reemerging viruses associated with WHO priority diseases. In: Nims R.W., Ijaz M.K., editors. Disinfection of Viruses. Intech Open; London, UK: 2022. - DOI
-
- U.S. CDC About Viral Hemorrhagic Fevers. Fact Sheet. [(accessed on 10 April 2025)]; Available online: https://www.cdc.gov/viral-hemorrhagic-fevers/about/index.html.
-
- Flórez-Álvarez L., de Souza E.E., Botosso V.F., de Oliveira D.B.L., Ho P.L., Taborda C.P., Palmisano G., Capurro M.L., Pinho J.R.R., Ferreira H.L., et al. Hemorrhagic fever viruses: Pathogenesis, therapeutics, and emerging and re-emerging potential. Front. Microbiol. 2022;13:1040093. doi: 10.3389/fmicb.2022.1040093. - DOI - PMC - PubMed
-
- World Health Organization Prioritizing Diseases for Research and Development in Emergency Contexts. 2021. [(accessed on 10 April 2025)]. Available online: https://www.who.int/activities/prioritizing-diseases-for-research-and-de....
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials